---
date created: 2024-11-18
tags:
  - meds
---
**Class:**
- Serotonin Partial Agonist and Reuptake Inhibitor (SPARI)

**Mechanism of Action (MOA):**
- Inhibits serotonin reuptake and partially agonizes serotonin 5-HT1A receptors.

**Indications/Uses:**
- Major Depressive Disorder (MDD)

**Side Effects:**
- Diarrhea
- Nausea
- Dizziness
- Insomnia
- Vomiting

**Adverse Effects:**
- Serotonin Syndrome
- Suicidal thoughts (especially in young adults and adolescents)

**Nursing Teaching and Implications:**
- Monitor for signs of serotonin syndrome.
- Educate about potential delay in therapeutic effects (several weeks).
- Advise to take with food to enhance absorption.
- Encourage reporting of any worsening depression or suicidal thoughts.

**Contraindications:**
- Concurrent use with MAO inhibitors
- Known hypersensitivity to vilazodone